STATNEWS: NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vacci
[link:https://www.statnews.com/2020/04/17/nih-partners-with-16-drug-companies-in-hopes-of-accelerating-covid-19-treatments-and-vaccines/|
WASHINGTON — The National Institutes of Health on Friday announced it would launch a sweeping public-private partnership between federal researchers and 16 pharmaceutical companies, aimed at coordinating and accelerating the development of Covid-19 treatments and vaccines.
The partnership, to be known as Accelerating Covid-19 Therapeutic Interventions and Vaccines, or ACTIV, is meant to standardize research between the federally funded researchers and a broad array of drug companies, and prioritize research into drugs and vaccines that are having high near-term potential.
“Now is the time to come together with unassailable objectivity to swiftly advance the development of the most promising vaccine and therapeutic candidates that can help end the COVID-19 global pandemic,” Francis Collins, the NIH director, said in a statement.
Much more at link.
